PlainPill

MK-2866 vs TB-500 for recovery

Short answer: For recovery, users rate them about the same: 97% report improvement with MK-2866 (60 reports) and 97% with TB-500 (208 reports).

MK-2866 has 0 meta-analyses and 0 randomized trials on PubMed; TB-500 has 0 and 3.

Based on 612 reports about MK-2866 and 652 about TB-500. Not medical advice.

MK-2866
SARM
TB-500
Peptide
User score3349
Verdict
Mixed
Mostly positive
Positive
of reports that state an outcome
39%67%
Reports612652
ResearchDResearch: NoneCResearch: Limited
Meta-analyses / RCTs0 / 00 / 3
Mainly used for
Weight loss
% reporting improvement
89% (80)100% (8)
Appetite
% reporting improvement
62% (8)100% (2)
Focus
% reporting improvement
71% (7)50% (2)
Energy
% reporting improvement
54% (37)50% (4)
Sleep
% reporting improvement
20% (20)60% (5)
Anxiety
% reporting improvement
33% (9)29% (7)
Mood
% reporting improvement
63% (49)89% (9)
Performance
% reporting improvement
88% (192)100% (17)
Recovery
% reporting improvement
97% (60)97% (208)
Pain & inflammation
% reporting improvement
70% (27)84% (168)
Digestion
% reporting improvement
—100% (2)
Libido
% reporting improvement
31% (45)—
Hormones
% reporting improvement
4% (82)—
Heart & lipids
% reporting improvement
0% (8)60% (5)
Skin & hair
% reporting improvement
33% (6)84% (19)
Immunity
% reporting improvement
—60% (5)
Common side effectssuppression, fatigue, insomnia, headacheanxiety, fatigue, dizziness, allergic reaction
Typical dose reportedNot listedNot listed
MK-2866
What a user said
“I've taken LDG-4033 and Ostarine from Ceretropic and noticed slight psychoactive effects from both, immediately (within 30 minutes after dosing).”
Full MK-2866 profile →
TB-500
What a user said
“They reduce neuroinflammation in the brain caused by either head injuries or drug abuse. Ive used them both for this and it works.”
Full TB-500 profile →

Related comparisons

Percentages come from first-hand user reports and are not clinical outcomes. Talk to a doctor before starting, stopping or combining anything. How we rate